I don't believe in coincidences myself. Amarin was certainly targeted. Dyke's and Reyna's handling of Marjac's rule 60 claim confirmed my suspicions. End of story.
Some or most of this could be addressed with a strong legal and public relations organization focused on smacking down this crap and acting proactively with positive information related to Vascepa. PR firms worth their salt have ways of flushing out the source of these lies and misrepresentations. Ketchum’s response on the call (prepared remarks) were reasonable. However, what good are they? The only ears that heard them were analysts and shareholders. We need the medical community to hear and see. Amarin isn’t assertive, which disappoints me greatly.
Personally I like it shows amarin is a threat and a real threat. I know we have some real struggles to work out but in the end I think this company survives and thrives most likely in the hands of a bp. Us shareholders IMO will be rewarded.
I am not one for conspiracy theories but the forces that have conspired to destroy and discredit Vascepa are clearly winning. ... As all of us know all too well, Amarin is a tiny player that barely has any market share. This compared to the fish oil industry that is several billion dollars and has zero data to say their product actually works, and more likely is causing real harm.
C'mon man ... Seriously ... the fish oil industry is much more interested in Vacepa good "reputation" (success) than Amarin....
What do you think: who will realize faster the first, additional billion if people will be interested in to take "fish oil" ... he fish oil industry or Amarin?